Name: AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals
Uploaded: 2024-02-02T08:02:58-05:00
Duration: 5 min
Description: (Reuters) – AbbVie Inc beat Wall Street estimates for fourth-quarter profit on Friday, helped by a smaller-than-expected decline in sales of its blockbuster drug, Humira, and strong demand for Botox amid stiff competition. Investors have been keeping a close eye on falling sales of arthritis drug Humira, which was until recently the world’s top-selling treatment. […]

Tag: Humira

AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals

(Reuters) – AbbVie Inc beat Wall Street estimates for fourth-quarter profit on Friday, helped by a smaller-than-expected decline in sales of its blockbuster drug, Humira, and strong demand for Botox amid stiff competition. Investors have been keeping a close eye on falling sales of arthritis drug Humira, which was until recently the world’s top-selling treatment. […]

CVS to Replace AbbVie’s Blockbuster Humira With Cheaper Rivals

(Bloomberg) — The biggest US drug-benefits manager is making a move that will take a bite out of sales for one of the world’s top-selling medications. Most Read from Bloomberg Starting April 1, CVS Health Corp. will no longer offer AbbVie Inc.’s Humira to most of the millions of patients in its commercial prescription plans. […]